Search research articles
Contact Us
Filters
Showing results (21-30 of 46) with videos related to
Page
of 5
Sort By:
Journal of Patient-Reported Outcomes
|
September 26, 2024
Economic burden and quality of life of caregivers of patients with sickle cell disease in the United Kingdom and France: a cross-sectional study
Martin Besser, Sian Bissell O'Sullivan, Siobhan Bourke, et al.
Pharmacoeconomics
|
April 21, 2011
Updated cost-effectiveness analysis of trastuzumab for early breast cancer: a UK perspective considering duration of benefit, long-term toxicity and pattern of recurrence
Peter S Hall, Claire Hulme, Christopher McCabe, et al.
BMJ Open
|
August 21, 2019
Measuring health-related quality of life in the general population and Roma communities in Romania: study protocol for two cross-sectional studies
Elena Olariu, Marian Sorin Paveliu, Eugen Baican, et al.
Dermatology and Therapy
|
April 22, 2025
Exploring Factors That Influence the Measurement of Patient-Reported Impacts of Alopecia Areata
Arash Mostaghimi, Adam Gibson, Georges Dwyer, et al.
Health and Quality of Life Outcomes
|
March 6, 2024
A time trade-off study to determine health-state utilities of transplant recipients with refractory cytomegalovirus infection with or without resistance
Waqas Ahmed, Louise Longworth, Yemi Oluboyede, et al.
Health and Quality of Life Outcomes
|
July 28, 2023
Population norms for the EQ-5D-3L and EQ-5D-5L in Romania
Elena Olariu, Raluca Caplescu, Luke Vale, et al.
Plos One
|
October 21, 2024
Treatment preferences in spinal muscular atrophy: A swing weighting study for caregivers of patients with SMA types 1 and 2
Anish Patel, Walter Toro, Siobhan Bourke, et al.
International Journal of Environmental Research and Public Health
|
July 24, 2021
Estimating an EQ-5D-3L Value Set for Romania Using Time Trade-Off
Marian Sorin Paveliu, Elena Olariu, Raluca Caplescu, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
June 10, 2022
EQ-5D-5L: a value set for Romania
Elena Olariu, Wael Mohammed, Yemi Oluboyede, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 11, 2025
Quality-adjusted time without symptoms or toxicity analysis of trastuzumab deruxtecan versus trastuzumab emtansine in HER2- positive metastatic breast cancer patients based on secondary use of the DESTINY-Breast03 trial
Natalie Dennis, Kyle Dunton, Christopher Livings, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 46) with videos related to
Sort By:
Page
of 5
Journal of Patient-Reported Outcomes
|
September 26, 2024
Economic burden and quality of life of caregivers of patients with sickle cell disease in the United Kingdom and France: a cross-sectional study
Martin Besser, Sian Bissell O'Sullivan, Siobhan Bourke, et al.
Pharmacoeconomics
|
April 21, 2011
Updated cost-effectiveness analysis of trastuzumab for early breast cancer: a UK perspective considering duration of benefit, long-term toxicity and pattern of recurrence
Peter S Hall, Claire Hulme, Christopher McCabe, et al.
BMJ Open
|
August 21, 2019
Measuring health-related quality of life in the general population and Roma communities in Romania: study protocol for two cross-sectional studies
Elena Olariu, Marian Sorin Paveliu, Eugen Baican, et al.
Dermatology and Therapy
|
April 22, 2025
Exploring Factors That Influence the Measurement of Patient-Reported Impacts of Alopecia Areata
Arash Mostaghimi, Adam Gibson, Georges Dwyer, et al.
Health and Quality of Life Outcomes
|
March 6, 2024
A time trade-off study to determine health-state utilities of transplant recipients with refractory cytomegalovirus infection with or without resistance
Waqas Ahmed, Louise Longworth, Yemi Oluboyede, et al.
Health and Quality of Life Outcomes
|
July 28, 2023
Population norms for the EQ-5D-3L and EQ-5D-5L in Romania
Elena Olariu, Raluca Caplescu, Luke Vale, et al.
Plos One
|
October 21, 2024
Treatment preferences in spinal muscular atrophy: A swing weighting study for caregivers of patients with SMA types 1 and 2
Anish Patel, Walter Toro, Siobhan Bourke, et al.
International Journal of Environmental Research and Public Health
|
July 24, 2021
Estimating an EQ-5D-3L Value Set for Romania Using Time Trade-Off
Marian Sorin Paveliu, Elena Olariu, Raluca Caplescu, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
June 10, 2022
EQ-5D-5L: a value set for Romania
Elena Olariu, Wael Mohammed, Yemi Oluboyede, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 11, 2025
Quality-adjusted time without symptoms or toxicity analysis of trastuzumab deruxtecan versus trastuzumab emtansine in HER2- positive metastatic breast cancer patients based on secondary use of the DESTINY-Breast03 trial
Natalie Dennis, Kyle Dunton, Christopher Livings, et al.
Page
of 5